Search Results

Alzheimer's drug: Hope -- and big profits; Newly approved Leqembi gains traction.

• Authors : Walsh, Dustin

• Source: Crain's Detroit Business. 2023, Vol. 39, Issue 27.

Record details

R&D NEWS.

• Source: Beverage Industry. 2023, Vol. 114, Issue 1.

Record details

An experimental Alzheimer's drug outperforms one just approved by the FDA

• Source: All Things Considered. July 17, 2023

Record details

FDA gives full approval to first drug to clearly, but modestly, slow Alzheimer's.

• Authors : McGinley, Laurie

• Source: The Washington Post. 2023.

Record details

Appeals court appears likely to restrict access to key abortion pill.

• Authors : Marimow, Ann E.

• Source: The Washington Post. 2023.

Record details

Thermo Fisher: FDA OKs Ncomine Dx Target Test as a Companion Diagnostic to Identify Patients Whose Tumors Have a HER2 (ERBB2).

• Source: Professional Services Close-Up. 2022.

Record details

FDA to okay second omicron-targeting booster for some, officials say.

• Authors : McGinley, Laurie; Sun, Lena H.

• Source: The Washington Post. 2023.

Record details

How Might Manufacturers of E-Cigarettes Get New Product and MRTP Orders from FDA More Quickly and Easily?

• Authors : Lindblom, Eric N.

• Source: Food and Drug Law Journal. 2018, Vol. 73, Issue 4, pages. 624

Record details

Impossible Foods Secures OK for Its Color Additive Petition from US FDA.

• Source: Entertainment Close-up. 2019.

Record details

Personalized Medicine: 2021 FDA Guideposts For Progress - Focus On Diagnostics.

• Authors : Konski, Antoinette

• Source: Mondaq Business Briefing. 2022.

Record details